The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection

被引:473
作者
Sieradzki, K
Roberts, RB
Haber, SW
Tomasz, A
机构
[1] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA
[2] Cornell Univ, Med Ctr, New York Hosp, New York, NY 10021 USA
[3] United Hosp, Med Ctr, Port Chester, NY USA
关键词
D O I
10.1056/NEJM199902183400704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:517 / 523
页数:7
相关论文
共 14 条
  • [1] [Anonymous], 1997, MMWR-MORBID MORTAL W, V46, P813
  • [2] Testing the efficacy of a molecular surveillance network: Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VREF) genotypes in six hospitals in the Metropolitan New York City Area
    deLencastre, H
    Severina, EP
    Roberts, RB
    Kreiswirth, BN
    Tomasz, A
    Larone, D
    Rahal, J
    Urban, C
    Montecalvo, M
    VanHorn, K
    Currie, B
    McKitrick, J
    Greene, W
    Spitzer, E
    Hargrave, J
    [J]. MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1996, 2 (03): : 343 - 351
  • [3] REASSESSMENT OF THE NUMBER OF AUXILIARY GENES ESSENTIAL FOR EXPRESSION OF HIGH-LEVEL METHICILLIN RESISTANCE IN STAPHYLOCOCCUS-AUREUS
    DELENCASTRE, H
    TOMASZ, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (11) : 2590 - 2598
  • [4] Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
    Hiramatsu, K
    Aritaka, N
    Hanaki, H
    Kawasaki, S
    Hosoda, Y
    Hori, S
    Fukuchi, Y
    Kobayashi, I
    [J]. LANCET, 1997, 350 (9092) : 1670 - 1673
  • [5] NOBLE WC, 1992, FEMS MICROBIOL LETT, V93, P195
  • [6] Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals
    Roberts, RB
    de Lencastre, A
    Eisner, W
    Severina, EP
    Shopsin, B
    Kreiswirth, BN
    Tomasz, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) : 164 - 171
  • [7] Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics
    Sieradzki, K
    Tomasz, A
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 : 47 - 51
  • [8] Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
    Sieradzki, K
    Villari, P
    Tomasz, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 100 - 107
  • [9] Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
    Sieradzki, K
    Tomasz, A
    [J]. JOURNAL OF BACTERIOLOGY, 1997, 179 (08) : 2557 - 2566
  • [10] Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
    Tenover, FC
    Lancaster, MV
    Hill, BC
    Steward, CD
    Stocker, SA
    Hancock, GA
    O'Hara, CM
    Clark, NC
    Hiramatsu, K
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (04) : 1020 - 1027